Nephrology

Imlifidase was granted a conditional marketing authorisation by the European Commission in August 2020 for “desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor.”36 This milestone launched a new era in kidney transplantation for selected patients who would previously have remained untreated.

Chronic kidney disease-associated pruritus (CKD-aP) is a systemic condition with a nondermatological cause, diagnosed once other potential aetiologies…

Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD) in which abnormalities in mineral homeostasis…

AAV encompasses a rare group of severe, progressive autoimmune diseases that involve a necrotising vasculitis and can affect many vital organs including…

The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are a group of rare inflammatory diseases including microscopic polyangiitis…

Haemodialysis was developed to alleviate symptoms due to accumulating uraemic toxins and acute fluid overload in patients with advancing chronic kidney…

At the 55th European Renal Association–European Dialysis and Transplant Association (ERA–EDTA) Congress in Copenhagen, Denmark, physicians from the USA…

The symposium reviewed the challenges in providing dialysis to patients with kidney disease and outlined data supporting the effectiveness of home…